0.5900USD+5800.00%Mkt Cap: 5.68M USDP/E: —Last update: 2026-05-22
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap5.68M USD
Enterprise Value17.09M USD
Revenue (TTM)1.03M USD
Gross Profit-8.47M USD
Net Income (TTM)-48.16M USD
Revenue/Share0.2460 USD
Last Price0.5900 USD
Fiscal Year EndDec 2024
MR QuarterSep 2024
Employees77
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.95
PEG—
EV/EBITDA-0.71
EV/Revenue16.51
P/S5.49
P/B-0.08
EPS (TTM)-11.44
EPS (Forward)0.61
52W Range
0.010026% of range2.270
52W High2.270 USD
52W Low0.0100 USD
Profitability
Gross Margin-818.55%
Oper. Margin-2196.25%
EBITDA Margin0.00%
Profit Margin-4653.62%
ROE128.44%
ROA-3565.14%
Growth
Revenue Growth215.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.08M USD
CapEx (TTM)263.00K USD
FCF Margin-524.83%
FCF Yield-95.57%
Net Debt17.09M USD
Net Debt/EBITDA-0.71
Balance Sheet
Debt/Equity-0.49
Current Ratio0.03
Quick Ratio0.00
Book Value/Sh-7.2520 USD
Cash/Share0.0210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 16, 2017
Splits
Last Split1:10
Split DateSep 25, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.80M
Float8.23M
Insiders46.36%
Institutions0.52%
Short Interest
Short Ratio2.4d
Short % Float1.33%
Short % Out.1.18%
Shares Short56.25K
Short (prev mo.)40.51K
Technical
SMA 500.3718 (+58.7%)
SMA 2000.3932 (+50.1%)
Beta3.07
S&P 52W Chg28.31%
Avg Vol (30d)1.63K
Avg Vol (10d)2.97K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—